Education
About Us
Working with TipRanks
Follow Us
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
8622 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.08 - HK$0.41
Previous CloseN/A
Volume952.00K
Average Volume (3M)498.13K
Market Cap
HK$177.67M
Enterprise ValueHK$37.48M
Total Cash (Recent Filing)-¥48.79M
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.54
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding500,472,000
10 Day Avg. Volume493,600
30 Day Avg. Volume498,133
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
8622 FAQ
What was Huakang Biomedical Holdings Company Limited’s price range in the past 12 months?
Huakang Biomedical Holdings Company Limited lowest stock price was HK$0.08 and its highest was HK$0.41 in the past 12 months.
What is Huakang Biomedical Holdings Company Limited’s market cap?
Huakang Biomedical Holdings Company Limited’s market cap is HK$177.67M.
When is Huakang Biomedical Holdings Company Limited’s upcoming earnings report date?
Huakang Biomedical Holdings Company Limited’s upcoming earnings report date is May 13, 2025 which is in 17 days.
How were Huakang Biomedical Holdings Company Limited’s earnings last quarter?
Huakang Biomedical Holdings Company Limited released its earnings results on Mar 28, 2025. The company reported -HK$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.005.
Is Huakang Biomedical Holdings Company Limited overvalued?
According to Wall Street analysts Huakang Biomedical Holdings Company Limited’s price is currently Overvalued.
Does Huakang Biomedical Holdings Company Limited pay dividends?
Huakang Biomedical Holdings Company Limited does not currently pay dividends.
What is Huakang Biomedical Holdings Company Limited’s EPS estimate?
Huakang Biomedical Holdings Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Huakang Biomedical Holdings Company Limited have?
Huakang Biomedical Holdings Company Limited has 500,472,000 shares outstanding.
What happened to Huakang Biomedical Holdings Company Limited’s price movement after its last earnings report?
Huakang Biomedical Holdings Company Limited reported an EPS of -HK$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.333%.
Which hedge fund is a major shareholder of Huakang Biomedical Holdings Company Limited?
Currently, no hedge funds are holding shares in HK:8622
---
Huakang Biomedical Holdings Company Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
251.48%
12-Months-Change
Fundamentals
Return on Equity
-7.93%
Trailing 12-Months
Asset Growth
-3.48%
Trailing 12-Months
Company Description
Huakang Biomedical Holdings Company Limited
Huakang Biomedical Holdings Company Limited (8622) is a company engaged in the biomedical sector, focusing on the research, development, production, and sale of healthcare products. The company offers a range of products that cater to various health and wellness needs, including biomedical and nutraceutical products.
---
Technical Analysis
Hang Tai Yue Group Holdings Ltd.
―
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
Beijing Gas Blue Sky Holdings Ltd
―
---